Keir has nearly 20 years of transactional experience in the biotech, pharmaceutical, and medtech industries. As a patent lawyer by training, Keir has represented companies of various sizes in all stages of transactions, including licensing and M&A. He is a seasoned life sciences executive in the oncology sector and has extensive experience raising capital in the public market space and has closed numerous deals including licenses, clinical collaborations, and strategic transactions with significant upfront payments. Prior to his role as Chief Executive Officer, Keir served as the Chief Business Officer for BlueSphere. Prior to joining BlueSphere, Keir was the Vice President of Business Development and General Counsel of OncoSec Medical Inc., a public, clinical-stage oncology company. Earlier in his career, he worked as a senior director for Advaxis, Inc., a late-stage, publicly traded, immuno-oncology company focused on developing, manufacturing and commercializing cancer vaccines, where he oversaw various legal, transaction and compliance functions.